Janice Cardenas’ Post

View profile for Janice Cardenas, graphic

eClinical Development Advisor - eCOA, RTSM, Telemedicine, eConsent, Supplies, EDC - Signant Health

In the light of recent draft guidances from FDA on core patient-reported outcomes (PROs) in cancer trials, and on dose optimization in oncology drug development (resulting from the Project Optimus initiative) – thoughtful collection and interpretation of patient experience data in oncology clinical research is becoming even more critical. 💡 Explore use cases and gain practical tips for implementing PROMs throughout oncology in our webinar on: ✍ 8th February at 4pm GMT https://bit.ly/47mhvQZ

To view or add a comment, sign in

Explore topics